T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. (2021)

First Author: Ogbe A
Attributed to:  Natural Killer Cells as Effectors in HIV Cure Strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-21856-3

PubMed Identifier: 33824342

Publication URI: http://europepmc.org/abstract/MED/33824342

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723